Switzerland squeezes drug prices, risking Roche/Novartis loyalty
This article was originally published in Scrip
Executive Summary
Switzerland has revealed plans to change its drug pricing plan from 2015 in an effort to reduce spending on pharmaceuticals, but the idea has met with stiff resistance from industry representatives, concerned at the impact on the country's home industry. Switzerland is home to two of the world's biggest drug manufacturers, Roche and Novartis.